ArticleMultiple sclerosis and related disorders2025
Concordance of Wearable Sensors and Depth Cameras for Quantitative Gait Assessment in Multiple Sclerosis.
Article in Multiple sclerosis and related disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundGait impairment is a primary driver of disability in multiple sclerosis (MS). However, traditional disability measures are nonlinear and lack sensitivity to subtle changes in motor function. Objective, scalable tools for gait assessment are critically needed.
objectiveTo evaluate the agreement between a depth-sensing video system and wearable inertial measurement unit (IMU) sensors in quantifying gait metrics in people with MS (pwMS), to assess the relationship to patient-reported disability.
methodsTwenty-six pwMS completed a 6-meter walk wearing IMU sensors (Clario OPAL) and were simultaneously recorded with a depth-sensing camera (Microsoft Kinect). Disability was self-reported using the Patient Determined Disease Step (PDDS) scale.
resultsParticipants had a median age of 54 years (range 23 - 71), 69 % were female, and the median disease duration was 65 months (0 - 382). Strong correlations with low differences were observed between devices for cadence (r > 0.9, p < 0.001; mean difference -5 steps/min), stride duration (r > 0.9, p < 0.001, mean difference 0.03-0.06 s), and gait speed (r = 0.7 - 0.9, p < 0.001, mean difference 0.04 - 0.15 m/s). Gait cycle phases were moderately correlated (r = 0.4 - 0.7). PDDS scores correlated most strongly with speed (r= -0.61), with weaker correlations across gait parameters.
interpretationWearable and depth video systems yielded highly correlated spatiotemporal gait data obtained in a clinical setting and are more sensitive to motor abnormalities than the PDDS. These tools could potentially be widely employed for clinical gait assessment, democratizing access to sensitive qualitative measurement of disease progression in MS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.